Celularity Inc
corporate_fare Company Profile
Celularity Inc (NASDAQ:CELU) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 29 items for CELU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for CELU spans DEF 14A, PRE 14A, 10-Q, SCHEDULE 13D/A.
Recent high-impact activity:
- Celularity Sets Dec 30 Vote on Nasdaq Share Issuance, With 10% Price Cut if Rejected
- Celularity Seeks Nasdaq Approval for Convertible Note Shares; 10% Price Cut if Vote Fails
- Celularity Q2 10-Q: Going Concern Reaffirmed, $0.6M Cash, Nasdaq Filing Deficiency
- Celularity Revenue Plunges 66% as Going-Concern Doubts Mount
- Celularity's Late 10-Q Reveals Going Concern Warning, $368K Cash, and Material Weaknesses
Financial Snapshot
Short Interest & Short Volume
2.33 days to coverFINRA reported short interest of 534,811 shares in CELU as of the October 30, 2026 settlement, a 21.1% increase from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 60.0% of CELU volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for CELU, detected from its recent SEC filings · based on capital-structure filings through 2026-09-25.
Director Buys $3.21M Convertible Notes · Warrants and Option for More Notes
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →